Sealey J E, Moon C, Laragh J H, Alderman M
Am J Med. 1976 Nov;61(5):731-8. doi: 10.1016/0002-9343(76)90154-6.
We previously demonstrated an inactive form of renin, termed prorenin, in the plasma of normal, hypertensive and anephric patients. Prorenin activity can be determined in plasma from the total renin activity after activation, minus the prior endogenous plasma renin activity. In the present study, conditions for cryoactivation of prorenin have been defined. Plasma prorenin is slowly converted to active renin-like material at -5 degrees C at pH 7.4. Activation takes four days and does not occur at pH 5.0. The degree of activation increases above pH 5 and is greatest between pH 7 and pH 9. Thus, almost no cryoactivation of prorenin occurs at the pH optimum for renin (5.7) in contrast to maximum activation at pH 7.4. No activation has been observed in the frozen state, but it does occur with decreasing rapidity at temperatures from -5 degress to +4 degress C. Since blood samples obtained for the determination of plasma renin activity are routinely chilled upon collection by most laboratories, some activatin of prorenin most likely occurs in all routine renin assays. The pH optimum of the enzymatic reaction of the activated prorenin in plasma is 5.8, the same as for renal renin, and the shape of the pH optimum curve is similar to that of renal renin added to human plasma. In a group of 23 normal subjects with plasma renin activity of 3.5 +/- 2.9 (SD), the activated prorenin increment was found to be significantly higher, 6.3 +/- 5.0 (SD) ng/ml/hour. Unlike plasma renin activity, prorenin activity in these normal subjects was directly related to the concentration of renin substrate (p less than 0.001). When the actual "concentration" of prorenin was calculated using renal renin as the reference standard, a direct relationship was also found between the concentration of prorenin and renin substrate (p less than 0.01). The observed relationship between prorenin and renin substrate concentrations might be a consequence of their regulation by common factors.
我们之前在正常、高血压和无肾患者的血浆中发现了一种无活性形式的肾素,称为前肾素。前肾素活性可通过激活后血浆中的总肾素活性减去先前内源性血浆肾素活性来测定。在本研究中,已确定了前肾素的冷冻激活条件。血浆前肾素在pH 7.4、-5℃时会缓慢转化为有活性的肾素样物质。激活需要四天时间,在pH 5.0时不会发生激活。激活程度在pH高于5时增加,在pH 7至pH 9之间最大。因此,与在pH 7.4时的最大激活相反,在前肾素的最适pH(5.7)下几乎不会发生冷冻激活。在冷冻状态下未观察到激活,但在从-5℃到+4℃的温度下,激活会以逐渐降低的速度发生。由于大多数实验室在采集用于测定血浆肾素活性的血样后通常会将其冷藏,因此在所有常规肾素测定中很可能会发生一些前肾素的激活。血浆中激活的前肾素的酶促反应的最适pH为5.8,与肾肾素相同,最适pH曲线的形状与添加到人体血浆中的肾肾素相似。在一组23名血浆肾素活性为3.5±2.9(标准差)的正常受试者中,发现激活的前肾素增量显著更高,为6.3±5.0(标准差)ng/ml/小时。与血浆肾素活性不同,这些正常受试者中的前肾素活性与肾素底物浓度直接相关(p<0.001)。当以前肾素的实际“浓度”作为参考标准计算时,也发现前肾素浓度与肾素底物之间存在直接关系(p<0.01)。观察到的前肾素与肾素底物浓度之间的关系可能是它们受共同因素调节的结果。